Skip to main content
. Author manuscript; available in PMC: 2010 Dec 8.
Published in final edited form as: Lancet. 2003 May 3;361(9368):1502–1510. doi: 10.1016/s0140-6736(03)13175-3

Figure 4. Four categories of treatment in the first 12 months for 47 kidney recipients whose grafts still function after 13–17 months.

Figure 4

Numbers represent category of treatment. 81–90% of patients in any given month were on tacrolimus monotherapy (category 1) or nearly so (category 2 and 3).

HHS Vulnerability Disclosure